-
SCC600
3DGROÖ HUMAN CRC ORGANOIDS (ISO72) (C005B-315495)
Price: $4,423.58List Price: $4,915.08Application Each vial contains >:1500 organoids. Mycoplasma: Negative Genotyped by STR analysis: Pass Human species verified Organoids are negative for HPV-16, HPV-18, Hepatitis A, B, C, and HIV-1 &: 2 viruses by PCR. -
A649878-100mg
Anti-inflammatory agent 35 (C007B-325680)
Price: $791.64List Price: $879.59Anti-inflammatory agent 35 (compound 5a27) is an orally active curcumin analogue with anti-inflammatory activity. Anti-inflammatory agent 35 blocks mitogen-activated protein kinase (MAPK) signaling and p65 nuclear translocation of NF-kB. -
A649878-10mg
Anti-inflammatory agent 35 (C007B-325681)
Price: $184.42List Price: $204.92Anti-inflammatory agent 35 (compound 5a27) is an orally active curcumin analogue with anti-inflammatory activity. Anti-inflammatory agent 35 blocks mitogen-activated protein kinase (MAPK) signaling and p65 nuclear translocation of NF-kB. -
A649878-25mg
Anti-inflammatory agent 35 (C007B-325682)
Price: $324.30List Price: $360.33Anti-inflammatory agent 35 (compound 5a27) is an orally active curcumin analogue with anti-inflammatory activity. Anti-inflammatory agent 35 blocks mitogen-activated protein kinase (MAPK) signaling and p65 nuclear translocation of NF-kB. -
ABT41
ANTI-MYOSIN XIX (MYO19) ANTIBODY (C005B-241867)
Price: $856.96List Price: $952.18Myosin XIX (Myo19) is the founding member of a novel class of myosin that associates with mitochondria. Both endogenous Myo19 and GFP-Myo19 exihibit localization to mitochondria. -
A413565-100mg
AZD5069 (C007B-020904)
Price: $1,124.88List Price: $1,249.86TargetsCXCR2In vitroAZD5069 is a slowly reversible antagonist of CXCR2 with effects of time and temperature evident on the pharmacology and binding kinetics.In vivoIn preclinical models, airway neutrophil recruitment in response to inflammatory -
A413565-10mg
AZD5069 (C007B-020905)
Price: $248.49List Price: $276.10TargetsCXCR2In vitroAZD5069 is a slowly reversible antagonist of CXCR2 with effects of time and temperature evident on the pharmacology and binding kinetics.In vivoIn preclinical models, airway neutrophil recruitment in response to inflammatory -
A413565-200mg
AZD5069 (C007B-020906)
Price: $1,947.16List Price: $2,163.51TargetsCXCR2In vitroAZD5069 is a slowly reversible antagonist of CXCR2 with effects of time and temperature evident on the pharmacology and binding kinetics.In vivoIn preclinical models, airway neutrophil recruitment in response to inflammatory -
A413565-25mg
AZD5069 (C007B-020907)
Price: $407.02List Price: $452.24TargetsCXCR2In vitroAZD5069 is a slowly reversible antagonist of CXCR2 with effects of time and temperature evident on the pharmacology and binding kinetics.In vivoIn preclinical models, airway neutrophil recruitment in response to inflammatory -
A413565-50mg
AZD5069 (C007B-020908)
Price: $595.82List Price: $662.03TargetsCXCR2In vitroAZD5069 is a slowly reversible antagonist of CXCR2 with effects of time and temperature evident on the pharmacology and binding kinetics.In vivoIn preclinical models, airway neutrophil recruitment in response to inflammatory -
A413565-5mg
AZD5069 (C007B-020909)
Price: $169.44List Price: $188.27TargetsCXCR2In vitroAZD5069 is a slowly reversible antagonist of CXCR2 with effects of time and temperature evident on the pharmacology and binding kinetics.In vivoIn preclinical models, airway neutrophil recruitment in response to inflammatory -
A426637-1ml
AZD5069 (C007B-021731)
Price: $312.66List Price: $347.40InformationAZD5069 AZD5069 is a novel antagonist of CXCR2 , which is shown to inhibit binding of CXCL8 to CXCR2 with a pIC50 value of 8.8 and inhibit CXCL8 binding to CXCR1 with pIC50 values of 6.5.TargetsCXCR2In vitroAZD5069 is a slowly reversible